Martin AM, Weber BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst. 2000;92:1126–35.
Article
CAS
PubMed
Google Scholar
Mencalha A, Victorino VJ, Cecchini R, Panis C. mapping oxidative changes in breast cancer: understanding the basic to reach the clinics. Anticancer Res. 2014;34(3):1127–40.
CAS
PubMed
Google Scholar
Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012;2012:137289–9.
PubMed Central
PubMed
Google Scholar
Sainz RM, Lombo F, Mayo JC. Radical decisions in cancer: redox control of cell growth and death. Cancers. 2012;4:442–74.
Article
PubMed Central
CAS
PubMed
Google Scholar
Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579–91.
Article
CAS
PubMed
Google Scholar
Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38(1):96–109.
Article
CAS
PubMed
Google Scholar
Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson LK, et al. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene. 2012;501(2):89–103.
Article
CAS
PubMed
Google Scholar
Cox DG, Tamimi RM, Hunter DJ. Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case–control study. BMC Cancer. 2006;6:217.
Article
PubMed Central
PubMed
Google Scholar
Mavaddat N, Dunning AM, Ponder BAJ, Easton DF, Pharoah PD. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Cancer Epidemiol Biomark Prev. 2009;18(1):255–9.
Article
CAS
Google Scholar
McCullough LE, Santella RM, Cleveland RJ, Bradshaw PT, Millikan RC, North KE, et al. Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk. Cancer Causes Control. 2012;23(12):1949–58.
Article
PubMed Central
PubMed
Google Scholar
Udler M, Maia A-T, Cebrian A, Brown C, Greenberg D, Shah M, et al. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol. 2007;25(21):3015–23.
Article
CAS
PubMed
Google Scholar
Kwee JK. A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr Jekyll and Mr Hyde. Biomed Res Int. 2014;2014:209845.
Article
PubMed Central
PubMed
Google Scholar
Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55–74.
Article
CAS
PubMed
Google Scholar
Hatfield DL, Tsuji PA, Carlson BA, Gladyshev VN. Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci. 2014;39(3):112–20.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhuo P, Diamond AM. Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta Gen Subj. 2009;1790(11):1546–54.
Article
CAS
Google Scholar
Brigelius-Flohe R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta. 2013;1830(5):3289–303.
Article
CAS
PubMed
Google Scholar
Peplonska B, Bukowska A, Sobala W, Reszka E, Gromadzinska J, Wasowicz W, et al. Rotating night shift work and mammographic density. Cancer Epidemiol Biomark Prev. 2012;21(7):1028–37.
Article
Google Scholar
Gromadzińska J, Peplonska B, Sobala W, Reszka E, Wasowicz W, Bukowska A, et al. Relationship between intensity of night shift work and antioxidant status in blood of nurses. Int Arch Occup Environ Health. 2013;86:923–30.
Article
PubMed Central
PubMed
Google Scholar
Brozek I, Cybulska C, Ratajska M, Piatkowska M, Kluska A, Balabas A, et al. Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet. 2011;52(3):325–30.
Article
PubMed Central
PubMed
Google Scholar
Wasowicz W, Nève J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39:2522–6.
CAS
PubMed
Google Scholar
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–69.
CAS
PubMed
Google Scholar
Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971;44(1):276–87.
Article
CAS
PubMed
Google Scholar
Sunderman FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem. 1970;16:903–10.
CAS
PubMed
Google Scholar
Portakal O, Ozkaya O, Inal ME, Bozan B, Kosan M, Sayek I. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem. 2000;33(4):279–84.
Article
CAS
PubMed
Google Scholar
Gupta RK, Patel AK, Kumari R, Chugh S, Shrivastav C, Mehra S, et al. Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a case control study. Asian Pac J Cancer Prev. 2012;13:6295–8.
Article
PubMed
Google Scholar
Kedzierska M, Olas B, Wachowicz B, Jeziorski A, Piekarski J. The lipid peroxidation in breast cancer patients. Gen Physiol Biophys. 2010;29(2):208–10.
CAS
PubMed
Google Scholar
Kumaraguruparan R, Subapriya R, Viswanathan P, Nagini S. Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin Chim Acta. 2002;325(1–2):165–70.
Article
CAS
PubMed
Google Scholar
Punnonen K, Ahotupa M, Asaishi K, Hyöty M, Kudo R, Punnonen R. Antioxidant enzyme activities and oxidative stress in human breast cancer. J Cancer Res Clin Oncol. 1994;120:374–7.
Article
CAS
PubMed
Google Scholar
Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, et al. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat. 2000;59:163–70.
Article
CAS
PubMed
Google Scholar
Tas F, Hansel H, Belce A, Ilvan S, Argon A, Camlica H, et al. Oxidative stress in breast cancer. Med Oncol. 2005;22(1):11–5.
Article
CAS
PubMed
Google Scholar
Montazerifar F, Hashemi M, Karajibani M, Sanadgol H, Dikshit M. Evaluation of lipid peroxidation and erythrocyte glutathione peroxidase and superoxide dismutase in hemodialysis patients. Saudi J Kidney Dis Transpl 2012, 23:274–9.
PubMed
Google Scholar
Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosella AM, Armstrong D. Correlates of markers of oxidative status in the general population. Am J Epidemiol 2001, 154:348–56.
Article
CAS
PubMed
Google Scholar
Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003;63:3347–51.
CAS
PubMed
Google Scholar
Jablonska E, Gromadzinska J, Reszka E, Wasowicz W, Sobala W, Szeszenia-Dabrowska N, et al. Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nutr. 2009;48(6):383–6.
Article
CAS
PubMed
Google Scholar
Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, et al. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood. 2007;109:3409–16.
Article
PubMed Central
CAS
PubMed
Google Scholar
Schulz R, Emmrich T, Lemmerhirt H, Leffler U, Sydow K, Hirt C, et al. Identification of a glutathione peroxidase inhibitor that reverses resistance to anticancer drugs in human B-cell lymphoma cell lines. Bioorg Med Chem Lett. 2012;22:6712–5.
Article
CAS
PubMed
Google Scholar
Zhao H, Liang D, Grossman HB, Wu XF. Glutathione peroxidase I gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology. 2005;66(4):769–74.
Article
PubMed
Google Scholar
Méplan C, Dragsted LO, Ravn-Haren G, Tjønneland A, Vogel U, Hesketh J. Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk. PloS One. 2013;8:e73316.
Article
PubMed Central
PubMed
Google Scholar
Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, et al. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Res. 2006;66:1225–33.
Article
CAS
PubMed
Google Scholar
Cox DG, Hankinson SE, Kraft P, Hunter DJ. No association between GPX1 Pro(198)Leu and breast cancer risk. Cancer Epidemiol Biomark Prev. 2004;13(11):1821–2.
CAS
Google Scholar
Ravn-Haren G, Olsen A, Tjonneland A, Dragsted LO, Nexo BA, Wallin H, et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis. 2006;27(4):820–5.
Article
CAS
PubMed
Google Scholar
Hu J, Zhou G-W, Wang N, Wang Y-J. GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;124:425–31.
Article
CAS
PubMed
Google Scholar
Arps DP, Healy P, Zhao L, Kleer CG, Pang JC. Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast. Breast Cancer Res Treat. 2013;138:719–26.
Article
PubMed Central
PubMed
Google Scholar
Jaworska K, Gupta S, Durda K, Muszynska M, Sukiennicki G, Jaworowska E, et al. A low selenium level is associated with lung and laryngeal cancers. PLoS One. 2013;8:3.
Article
Google Scholar
Jablonska E, Gromadzinska J, Klos A, Bertrandt J, Skibniewska K, Darago A, et al. Selenium, zinc and copper in the Polish diet. J Food Compos Anal. 2013;31:259–65.
Article
CAS
Google Scholar
Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L. Selenium in breast cancer. Oncology. 2003;64(3):227–31.
Article
CAS
PubMed
Google Scholar
Suzana S, Cham BG, Ahmad RG, Mohd RR, Fairulnizal MN, Normah H, et al. Relationship between selenium and breast cancer: a case–control study in the Klang Valley. Singap Med J. 2009;50(3):265–9.
CAS
Google Scholar
van’t Veer P, van der Wielen RP, Kok FJ, Hermus RJ, Sturmans F. Selenium in diet, blood, and toenails in relation to breast cancer: a case–control study. Am J Epidemiol. 1990;131(6):987–94.
Google Scholar
Garland M, Morris JS, Colditz GA, Stampfer MJ, Spate VL, Baskett CK, et al. Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol. 1996;144:653–60.
Article
CAS
PubMed
Google Scholar
Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, Willett WC. A prospective study of selenium status and breast cancer risk. JAMA. 1990;264(9):1128–31.
Article
CAS
PubMed
Google Scholar
van Noord PA, Maas MJ, van der Tweel I, Collette C. Selenium and the risk of postmenopausal breast cancer in the DOM cohort. Breast Cancer Res Treat. 1993;25(1):11–9.
Article
PubMed
Google Scholar
van Noord PA, Collette HJ, Maas MJ, de Waard F. Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol. 1987;16(2):318–22.
Article
PubMed
Google Scholar
He N, Shi X, Zhao Y, Tian L, Wang D, Yang X. Inhibitory effects and molecular mechanisms of selenium-containing tea polysaccharides on human breast cancer MCF-7 cells. J Agric Food Chem. 2013;61:579–88.
Article
CAS
PubMed
Google Scholar
Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, et al. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res. 2005;65:3487–92.
CAS
PubMed
Google Scholar
Vekariya KK, Kaur J, Tikoo K. ER alpha signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer. Nanomed Nanotechnol Biol Med. 2012;8(7):1125–32.
Article
CAS
Google Scholar